Compass Oncology
- Research works
- 75 ▼ 34% vs 2018-21
- Citations
- 1.3k 17.2 per fractional work
- Top-10% rate
- 13.8% all institutions 10.0%
- Open access
- 44% world 40%
- International
- 16% world 18%
Not ranked overall: Compass Oncology is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Compass Oncology work in?
In all years, 76% of research at Compass Oncology is in Health Sciences, 16% in Life Sciences. Its largest fields are Medicine (73%), Biochemistry, Genetics and Molecular Biology (14%), Economics, Econometrics and Finance (4%). It does 2.9× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 19 fields, with their numbers
- Health Sciences5775.9%
- Medicine5572.5%
- Health Professions22.9%
- Dentistry00.2%
- Nursing00.1%
- Veterinary00.1%
- Life Sciences1216.2%
- Social Sciences56.1%
- Economics, Econometrics and Finance33.5%
- Social Sciences22.1%
- Psychology00.4%
- Arts and Humanities00.1%
- Physical Sciences11.9%
- Environmental Science11.1%
- Physics and Astronomy00.3%
- Mathematics00.2%
- Earth and Planetary Sciences00.1%
- Computer Science00.1%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.7×. Every wedge is a field page.
All 12 fields, with their numbers
- Pharmacology, Toxicology and Pharmaceutics5.66×0 works
- Veterinary4.89×0 works
- Medicine3.73×12 works
- Economics, Econometrics and Finance3.70×1 works
- Biochemistry, Genetics and Molecular Biology2.61×2 works
- Dentistry0.59×0 works
- Health Professions0.41×0 works
- Arts and Humanities0.17×0 works
- Physics and Astronomy0.15×0 works
- Agricultural and Biological Sciences0.14×0 works
- Computer Science0.06×0 works
- Social Sciences0.04×0 works
- Pharmacology, Toxicology and Pharmaceutics 5.7×
- Veterinary 4.9×
- Medicine 3.7×
- Economics, Econometrics and Finance 3.7×
- Biochemistry, Genetics and Molecular Biology 2.6×
- Dentistry 0.6×
- Health Professions 0.4×
- Arts and Humanities 0.2×
- Physics and Astronomy 0.1×
- Agricultural and Biological Sciences 0.1×
- Computer Science 0.1×
- Social Sciences 0.0×
Who are the top researchers at Compass Oncology?
Ranked on the quality score, Ian D. Schnadig, Spencer H. Shao and Michael J. Klepper lead among researchers whose main affiliation is Compass Oncology.
- 1
Ian D. Schnadig
United States · #364,259 worldwide 2.4k citations · 64 works
- 2
Spencer H. Shao
United States · #837,698 worldwide 2.2k citations · 23 works
- 3
Michael J. Klepper
United States · #3,778,190 worldwide 140 citations · 19 works
- 4
Lucy R. Langer
United States · #3,815,329 worldwide 73 citations · 20 works
- 5
Christof P Erickson
United States · #4,535,174 worldwide 414 citations · 39 works
- 6
Antoanella Calame
United States · #5,042,297 worldwide 891 citations · 89 works
- 7
Jay Clarence Andersen
United States · #5,064,035 worldwide 102 citations · 55 works
Which keywords describe research at Compass Oncology?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Clinical Practice Guidelines, Prognostic Factors, Survival Analysis, Rituximab, Palliative Care, Precision Medicine and Quality of Life.
- Genetic Pathogenesis
- Molecular Profiling
- Genetic Testing
- Mutational Signatures
- Cancer Genomics
- Metastasis
- Genomic Aberrations
- Lymphoma
- Brachytherapy
- PET Imaging
- Cancer Risk
- Molecular Classification
- Cervical Cancer
- Targeted Therapy
- Clinical Trials
- End-of-Life
- Precision Medicine
- Rituximab
- Survival Analysis
- Clinical Practice Guidelines
- Chemotherapy
- Prognostic Factors
- Quality of Life
- Palliative Care
- Breast Cancer
- Immunotherapy
- Radiation Therapy
- Sentinel Lymph Node Biopsy
- Radiotherapy
- Advance Care Planning
- Family Perspectives
- Robotic Surgery
- Endometrial Carcinoma
- Chronic Lymphocytic Leukemia
- Genomic Instability
- Molecular Subtypes
- Metastatic Breast Cancer
- Neoadjuvant Therapy
- Gene Expression Profiling
- Ovarian Cancer
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy7▲ 13×19 topics
- Clinical Practice Guidelines6▲ 14×8 topics
- Prognostic Factors6▲ 17×12 topics
- Survival Analysis5▲ 27×6 topics
- Quality of Life5▲ 4.9×13 topics
- Rituximab5▲ 40×3 topics
- Palliative Care4▲ 34×3 topics
- Precision Medicine4▲ 17×5 topics
- Breast Cancer4▲ 18×7 topics
- End-of-Life4▲ 60×2 topics
- Immunotherapy4▲ 7.0×10 topics
- Clinical Trials3▲ 7.3×11 topics
- Radiation Therapy3▲ 31×4 topics
- Targeted Therapy3▲ 21×4 topics
- Sentinel Lymph Node Biopsy3▲ 63×2 topics
- Cervical Cancer3▲ 40×2 topics
- Radiotherapy3▲ 10×10 topics
- Molecular Classification3▲ 25×2 topics
- Advance Care Planning3▲ 64×1 topic
- Cancer Risk3▲ 14×4 topics
- Family Perspectives3▲ 64×1 topic
- PET Imaging3▲ 16×4 topics
- Robotic Surgery3▲ 26×2 topics
- Brachytherapy2▲ 90×1 topic
- Endometrial Carcinoma2▲ 90×1 topic
- Lymphoma2▲ 23×2 topics
- Chronic Lymphocytic Leukemia2▲ 66×1 topic
- Genomic Aberrations2▲ 66×1 topic
- Genomic Instability2▲ 26×3 topics
- Metastasis2▲ 9.5×7 topics
- Molecular Subtypes2▲ 37×2 topics
- Cancer Genomics2▲ 56×1 topic
- Metastatic Breast Cancer2▲ 46×2 topics
- Mutational Signatures2▲ 56×1 topic
- Neoadjuvant Therapy2▲ 14×4 topics
- Genetic Testing2▲ 18×2 topics
- Gene Expression Profiling2▲ 29×2 topics
- Molecular Profiling2▲ 24×2 topics
- Ovarian Cancer2▲ 30×3 topics
- Genetic Pathogenesis2▲ 44×1 topic
Which research topics does Compass Oncology publish most on?
By volume in 2022-now: Chronic Myeloid Leukemia Treatments, Colorectal Cancer Treatments and Studies, Chronic Lymphocytic Leukemia Research and Economic and Financial Impacts of Cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Chronic Myeloid Leukemia Treatments Hematology 1 works
- 2 Colorectal Cancer Treatments and Studies Oncology 1 works
- 3 Chronic Lymphocytic Leukemia Research Genetics 1 works
- 4 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
- 5 Cancer Genomics and Diagnostics Cancer Research 1 works
- 6 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 0 works
- 7 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
- 8 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
- 9 BRCA gene mutations in cancer Genetics 0 works
- 10 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Compass Oncology's research output changed?
Output in 2022-2025 was 34% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Compass Oncology as a percentage of every work published that year, 0.000082% in 2024.
Fractional works of Compass Oncology over all fractional works that year. How the balance of science has shifted.
Other research institutions in Portland
- Oregon Health & Science University
- Portland State University
- University of Portland
- Lewis & Clark College
- Reed College
- Oregon Medical Research Center
- Concordia University
- Legacy Health
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Compass Oncology. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.